News

August 13, 2025

Avista Therapeutics and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership

April 30, 2025

Avista Therapeutics Presents In Vivo Data for its AAV Capsid in Inherited Retinal Diseases at Association for Research in Vision and Ophthalmology 2025 Annual Meeting

>

April 30, 2025

Avista Therapeutics Announces Oral Presentation at ARVO 2025 Annual Meeting

>

Jan. 7, 2025

Avista Therapeutics Appoints Steven Altschuler, MD, as Chairman of the Board of Directors

>

July 20, 2022

Avista Therapeutics Partners with Roche to Develop Next-Generation AAV Gene Therapy Vectors for Ocular Diseases

>